Skip to main content

Month: June 2024

Piedmont REIT signs over 575,000 SF of Leases During April and May 2024

Brings YTD leasing to Approximately 1.1 million SF Atlanta, June 03, 2024 (GLOBE NEWSWIRE) — Piedmont Office Realty Trust, Inc. (“Piedmont” or “the Company”) (NYSE:PDM), an owner of Class A office properties located primarily in the Sunbelt, announced today, that the Company will be participating at this week’s NAREIT Investor Conference in New York City. The Company will be noting that it has completed over 575,000 square feet of leasing thus far in the second quarter of 2024, with approximately 60% of this total leased square footage related to new tenants and bringing year-to-date leasing volume to approximately 1.1 million square feet. The largest lease completed thus far in the second quarter was for the relocation of Travel + Leisure Co’s (NYSE:TNL) headquarters to Piedmont’s 501 W Church Street property in downtown,...

Continue reading

Microchip Technology to Present at the Bank of America 2024 Global Technology Conference

CHANDLER, Ariz., June 03, 2024 (GLOBE NEWSWIRE) — (NASDAQ:MCHP) – Microchip Technology Incorporated, a leading provider of smart, connected, and secure embedded control solutions, today announced that the Company will present at the Bank of America Global Technology Conference on Wednesday, June 5, 2024 at 2:40 p.m. (Pacific Time). Presenting for the Company will be Mr. Eric Bjornholt, Senior Vice President and Chief Financial Officer. A live webcast of the presentation will be made available by B of A, and can be accessed on the Microchip website at www.microchip.com. Any forward looking statements made during the presentation are qualified in their entirety by the discussion of risks set forth in the Company’s Securities and Exchange Commission filings. Copies of SEC filings can be obtained for free at the SEC’s website...

Continue reading

Press Release: ASCO: Sarclisa is first anti-CD38 to significantly improve progression-free survival in combination with VRd for newly diagnosed transplant-ineligible multiple myeloma in phase 3

ASCO: Sarclisa is first anti-CD38 to significantly improve progression-free survival in combination with VRd for newly diagnosed transplant-ineligible multiple myeloma in phase 3Sarclisa, in combination with standard-of-care bortezomib, lenalidomide and dexamethasone (VRd) followed by Sarclisa-Rd reduced the risk of recurrence or death by 40% versus VRd followed by Rd in the investigational use for transplant-ineligible newly diagnosed multiple myeloma patients Key primary endpoint of progression-free survival met, demonstrating Sarclisa’s potential as a first-in-class combination to address gaps in care for newly diagnosed transplant-ineligible patients Full data simultaneously published in NEJM and formed the basis of regulatory submissionsParis, June 3, 2024. Data from the IMROZ phase 3 study demonstrated Sarclisa (isatuximab)...

Continue reading

Sun Communities, Inc. Declares Second Quarter 2024 Distribution

Southfield, MI, June 03, 2024 (GLOBE NEWSWIRE) — Sun Communities, Inc. (NYSE: SUI) (the “Company”) a real estate investment trust (“REIT”) that owns and operates, or has an interest in, manufactured housing (“MH”) and recreational vehicle (“RV”) communities and marinas (collectively, the “properties”), today announced its Board of Directors declared a quarterly distribution of $0.94 per share of common stock for the second quarter of 2024. The distribution is payable on July 15, 2024 to shareholders of record on June 28, 2024. About Sun Communities, Inc. Sun Communities, Inc. is a REIT that, as of March 31, 2024, owned, operated, or had an interest in a portfolio of 665 developed properties comprising approximately 180,110 developed sites and approximately 48,040 wet slips and dry storage spaces in the United States,...

Continue reading

TopBuild Acquires Texas Insulation from Energy One America

DAYTONA BEACH, Fla., June 03, 2024 (GLOBE NEWSWIRE) — TopBuild Corp. (NYSE:BLD), a leading installer and specialty distributor of insulation and related building material products to the construction industry in the United States and Canada, announced today that it has acquired Texas Insulation, which generates approximately $39 million in annual revenue. Texas Insulation operates out of three locations in Dallas, Houston, and Austin and serves customers in the residential and light commercial end markets. The company installs primarily spray foam as well as fiberglass insulation. Robert Buck, President and CEO of TopBuild, said, “Texas Insulation expands our spray foam capabilities in an important and growing geography, and further demonstrates our opportunities around making acquisitions in our core area of insulation. We are...

Continue reading

GitLab Reports First Quarter Fiscal Year 2025 Financial Results

First Quarter Fiscal Year 2025 Highlights:Total revenue of $169.2 million, up 33% year-over-year Significant year-over-year GAAP and Non-GAAP operating margin expansion Operating cash flow of $38.1 million and Non-GAAP adjusted free cash flow of $37.4 millionSAN FRANCISCO, June 03, 2024 (GLOBE NEWSWIRE) — GitLab Inc. (NASDAQ: GTLB), The DevSecOps Platform, today reported financial results for its first quarter fiscal year 2025, ended April 30, 2024. “GitLab continues to differentiate our platform with AI-driven software innovations that are streamlining how customers build, test, secure, and deploy software,” said Sid Sijbrandij, GitLab CEO and co-founder. “Our results show that customers see the value of our end-to-end DevSecOps platform, which enables them to leverage AI throughout the software development lifecycle and enhance...

Continue reading

Lavoro Reports Fiscal Third Quarter 2024 Earnings Results¹

3Q24 revenue grew 6% to $514.2 million. Growth was driven by continued market share gains and volume growth, which mitigated ongoing deflation in input prices throughout Brazil and Colombia. Gross profit decreased -16% to $60.2 million. Gross margins narrowed by -310 basis points to 11.7%, primarily due to the ongoing input price deflation and a less favorable sales mix resulting from a greater proportion of low margin Grain revenue. The Crop Care segment remained a strong performer, with revenue rising 30% to $22.1 million and gross profit up 14% to $9.1 million, mainly fueled by robust growth in biological products. Net loss for 3Q24 narrowed to $64.8 million from a loss of $74.3 million in the prior year quarter. This improvement reflects the absence of last year’s Nasdaq listing non-recurring expenses, partially offset by lower...

Continue reading

HealthEquity Reports First Quarter Ended April 30, 2024 Financial Results

Highlights of the first quarter include:Revenue of $287.6 million, an increase of 18% compared to $244.4 million in Q1 FY24. Net income of $28.8 million, compared to $4.1 million in Q1 FY24, with non-GAAP net income of $70.3 million, an increase of 64% compared to $42.8 million in Q1 FY24. Net income per diluted share of $0.33, compared to $0.05 in Q1 FY24, with non-GAAP net income per diluted share of $0.80, compared to $0.50 in Q1 FY24. Adjusted EBITDA of $117.4 million, an increase of 36% compared to $86.6 million in Q1 FY24. 9.1 million HSAs, an increase of 13% compared to Q1 FY24. Total HSA Assets of $27.3 billion, an increase of 22% compared to Q1 FY24. 16.0 million Total Accounts, including both HSAs and complementary CDBs, an increase of 7% compared to Q1 FY24. The Company completed its acquisition of the BenefitWallet HSA portfolio...

Continue reading

Nokia Corporation: Repurchase of own shares on 03.06.2024

Nokia CorporationStock Exchange Release03 June 2024 at 22:30 EEST Nokia Corporation: Repurchase of own shares on 03.06.2024 Espoo, Finland – On 03 June 2024 Nokia Corporation (LEI: 549300A0JPRWG1KI7U06) has acquired its own shares (ISIN FI0009000681) as follows:Trading venue (MIC Code) Number of shares Weighted average price / share, EUR*XHEL 356,389 3.65CEUX – –BATE – –AQEU – –TQEX – –Total 356,389 3.65* Rounded to two decimals On 25 January 2024, Nokia announced that its Board of Directors is initiating a share buyback program to return up to EUR 600 million of cash to shareholders in tranches over a period of two years. The first phase of the share buyback program in compliance with the Market Abuse Regulation (EU) 596/2014 (MAR), the Commission Delegated Regulation...

Continue reading

CloudMD Announces Filing and Mailing of the Management Information Circular in Connection with the Proposed Go-Private Transaction with CPS Capital

Your vote is important no matter how many shares you hold. The Board of Directors of CloudMD unanimously recommends that Securityholders vote IN FAVOUR of the Arrangement Resolution. Questions or requests for voting assistance may be directed to Laurel Hill Advisory Group by telephone at 1.877.452.7184 or by email at assistance@laurelhill.com.TORONTO, June 03, 2024 (GLOBE NEWSWIRE) — CloudMD Software & Services Inc. (TSXV: DOC, Frankfurt: 6PH) (the “Company” or “CloudMD”), is pleased to announce the notice of special meeting (the “Meeting”) of the holders (“Shareholders”) of common shares of CloudMD (“Shares”) and of the holders (the “Optionholders”, and collectively with the Shareholders, the “Securityholders”) of stock options of the Company and management information circular (the “Circular”) are now available on CloudMD’s...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.